# Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes

> **NCT05854069** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 140 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **BEHAVIORAL:** FAMS-T1D
- **BEHAVIORAL:** Digital resources for diabetes

## Key facts

- **NCT ID:** NCT05854069
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-30
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-10-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05854069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05854069, "Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05854069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*